Scientists identify protein which could improve treatments for recurrent miscarriages and pre-eclampsia

Scientists at the Centre for Stem Cell Biology (CSCB), a research group within BMS, have identified a protein, involved in the development of the human placenta, may also help embryos implant in the womb – something which could improve treatments for recurrent miscarriages and pre-eclampsia.

The pioneering study, lead by  CSCB co-director Professor Harry Moore, shows that a protein called Syncytin-1, which was the result of a viral infection of our primate ancestors 25 million years ago, is first secreted on the surface of a developing embryo even before it implants in the womb.

This means the protein is likely to play a major role in helping embryos stick to the womb as well as the formation of the placenta.

Read more at the University Media Centre